ArticleThoracic cancer2023

Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC.

Xiya Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.